Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
4.52 Up 0.02(0.44%) Apr 17, 4:00PM EDT
|After Hours : 4.70 Up 0.18 (3.98%) Apr 17, 5:12PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 7,823   6,856   18,452   14,655  
Cost of Revenue -   -   -   -  
Gross Profit 7,823   6,856   18,452   14,655  
Operating Expenses
Research Development30,055  37,630  42,465  36,989  
Selling General and Administrative6,010  5,150  5,095  4,932  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (28,242) (35,924) (29,108) (27,266)
Income from Continuing Operations
Total Other Income/Expenses Net373  107  150  163  
Earnings Before Interest And Taxes(27,869)(35,817)(28,958)(27,103)
Interest Expense4,479  3,946  1,293  1,220  
Income Before Tax(32,348)(39,763)(30,251)(28,323)
Income Tax Expense -   -   -   -  
Minority Interest(711)132  169  170  
Net Income From Continuing Ops(33,059)(39,631)(30,082)(28,153)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (33,059) (39,631) (30,082) (28,153)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (33,059) (39,631) (30,082) (28,153)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.